Quent Capital LLC Trims Stock Position in Danaher Corporation $DHR

Quent Capital LLC reduced its stake in shares of Danaher Corporation (NYSE:DHR) by 8.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,418 shares of the conglomerate’s stock after selling 223 shares during the quarter. Quent Capital LLC’s holdings in Danaher were worth $478,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. GHP Investment Advisors Inc. grew its position in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after buying an additional 99 shares during the period. Sierra Ocean LLC grew its position in shares of Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after buying an additional 76 shares during the period. Smallwood Wealth Investment Management LLC purchased a new stake in shares of Danaher in the 1st quarter worth about $31,000. Dunhill Financial LLC grew its position in shares of Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock worth $34,000 after buying an additional 67 shares during the period. Finally, Costello Asset Management INC purchased a new stake in shares of Danaher in the 1st quarter worth about $41,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Performance

Shares of Danaher stock opened at $215.05 on Friday. The stock has a market cap of $153.98 billion, a price-to-earnings ratio of 45.75, a PEG ratio of 3.06 and a beta of 0.77. The firm’s 50-day moving average is $200.19 and its 200 day moving average is $197.33. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.41. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business’s revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio is currently 27.23%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on DHR. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a research report on Tuesday, September 2nd. Wells Fargo & Company reduced their target price on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 23rd. Scotiabank raised shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 target price on the stock in a research report on Friday, July 11th. Guggenheim reiterated a “buy” rating and issued a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Finally, Robert W. Baird upped their price target on shares of Danaher from $225.00 to $226.00 and gave the stock an “outperform” rating in a research note on Friday, July 18th. Seventeen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $245.91.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the company’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.